Maternal Mortality Care / 3 Overdue 4 Overly

Quranayati Quranayati

doi:10.22146/rpcpe.69543

Maternal Mortality Care / 3 Overdue 4 Overly

https://doi.org/10.22146/rpcpe.69543

Quranayati Quranayati^(1*)

(1) dr Zainoel Abidin General Hospital Banda Aceh; Indonesia
(*) Corresponding Author

Abstract

Preeclampsia is a hypertensive condition that occurs in pregnant women whose gestational age has reached 20 weeks or after delivery who previously had normal blood pressure and increased to 140/90 mmHg or more. Preeclampsia condition is a vasospastic disease that involves many systems and is characterized by hemoconcentration, hypertension, and proteinuria >300 mg/24 hours. These symptoms can be seen during pregnancy, childbirth and in the puerperium which can be accompanied by convulsions and coma. Preeclampsia is one of the causes of maternal and perinatal mortality, and can be detected at gestational age >34 weeks with blood pressure < 140 /110 mmHg, then the patient may have preeclampsia.

Keywords

preeclampsia, hypertensi in pregnancy, maternal mortality

Full Text:

PDF

References

1. Ertiana D, Wulan SR. The relationship between age and the incidence of preeclampsia in pregnant women at Kediri District Hospital in 2018. Jurnal Kebidanan Midwiferia. 2019;5(2):24-30.

2. Bardja S. Risk factors for severe preeclampsia/eclampsia in pregnant women. EMBRIO. 2020;12(1):18-30.

3. Situmorang TH, Damantalm Y, Januarista A, Sukri S. Factors related to the incidence of preeclampsia in pregnant women at the KIA Poly Hospital Anutapura Palu. Healthy Tadulako Journal (Jurnal Kesehatan Tadulako). 2016;2(1):34-44.

4. Le Y, Ye J, Lin J. Expectant management of early-onset severe preeclampsia: a principal component analysis. Annals of Translational Medicine. 2019;7(20):519.

5. Ministry of Health, Republic of Indonesia. Indonesian Health Profile 2019. Jakarta: Ministry of Health of the Republic of Indonesia; 2019.

6. Muhani N, Besral B. Severe pre-eclampsia and maternal mortality. Kesmas: Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal). 2015;10(2):80-6.

7. Tolinggi S, Mantualangi K, Nuryani N. Preeclampsia incidence and risk factors that affect it. Gorontalo Journal of Public Health. 2018;1(2):85-91.

8. Gustri Y, Sitorus RJ, Utama F. Determinants of the incidence of preeclampsia in pregnant women in RSUP Dr. Mohammad Hoesin Palembang. Jurnal Ilmu Kesehatan Masyarakat. 2016;7(3).

9. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Anticonvulsants for women with pre-eclampsia. The Cochrane Database of Systematic Reviews. 2000(2):CD000025.

10. Ayakusuma, AAN. Risk management in preeclampsia (efforts to reduce the incidence of preeclampsia with a risk-based approach). Denpasar: FK Bagian/SMF Obstetri dan Ginekologi FK Unud/RS Sanglah; 2015.

11. Widiastuti YP, Rimawati U, Istioningsih I. Body mass index (BMI), pregnancy distance and history of hypertension affect the incidence of preeclampsia. Jurnal Ilmu Keperawatan Maternitas. 2019;2(2):6-22.

12. Fegita P, Satria PH. Hemorrhagic post partum: syok hemorrhagic ec late hemorrhagic post partum. Jurnal Kesehatan Andalas. 2018;7:71-5.

13. GKIA. Catalog in publication (KDT) 1001 steps to save mother and child/GKIA. Jakarta : Pustaka Bunda; 2016.

DOI: https://doi.org/10.22146/rpcpe.69543